Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ADRX-0405 |
Synonyms | |
Therapy Description |
Limited information is available on ADRX-0405, a putative antibody-drug conjugate (ADC) targeting STEAP1 (Dec 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ADRX-0405 | ADRX 0405|ADRX0405 | Limited information is available on ADRX-0405, a putative antibody-drug conjugate (ADC) targeting STEAP1 (Dec 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06710379 | Phase I | ADRX-0405 | A Study of ADRX-0405 in Subjects with Select Advanced Solid Tumors | Recruiting | USA | 0 |